Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Seeks Withdrawal Of Injectable Bacitracin Despite Extensive Off-Label Use
Jan 31 2020
•
By
Sue Sutter
US FDA has asked ANDA sponsors to stop selling injectable bacitracin. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Pink Sheet